N-(5-Carbamoyl-2-(4-(2-oxopyridin-1(2H)-yl)benzamido)phenyl)-3,4,5-trimethoxybenzamide

ID: ALA3612123

Chembl Id: CHEMBL3612123

PubChem CID: 122187958

Max Phase: Preclinical

Molecular Formula: C29H26N4O7

Molecular Weight: 542.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)Nc2cc(C(N)=O)ccc2NC(=O)c2ccc(-n3ccccc3=O)cc2)cc(OC)c1OC

Standard InChI:  InChI=1S/C29H26N4O7/c1-38-23-15-19(16-24(39-2)26(23)40-3)29(37)32-22-14-18(27(30)35)9-12-21(22)31-28(36)17-7-10-20(11-8-17)33-13-5-4-6-25(33)34/h4-16H,1-3H3,(H2,30,35)(H,31,36)(H,32,37)

Standard InChI Key:  XFVKIKGQWBDVRC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3612123

    ---

Associated Targets(Human)

F10 Tclin Coagulation factor X (9693 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

F10 Coagulation factor X (318 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 542.55Molecular Weight (Monoisotopic): 542.1801AlogP: 3.47#Rotatable Bonds: 9
Polar Surface Area: 150.98Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.50CX Basic pKa: CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.29Np Likeness Score: -1.03

References

1. Yang J, Su G, Ren Y, Chen Y..  (2015)  Synthesis of 3,4-diaminobenzoyl derivatives as factor Xa inhibitors.,  101  [PMID:26114810] [10.1016/j.ejmech.2015.06.012]

Source